Results 21 to 30 of about 177,501 (382)

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

New England Journal of Medicine, 2021
Background Reports have suggested an association between the development of myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus disease 2019 (Covid-19), but the frequency and severity of myocarditis after vaccination have not
G. Witberg, N. Barda, S. Hoss, Ilan Richter, M. Wiessman, Y. Aviv, T. Grinberg, Oren Auster, N. Dagan, R. Balicer, R. Kornowski   +10 more
semanticscholar   +1 more source

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Nature Network Boston, 2021
Although myocarditis and pericarditis were not observed as adverse events in coronavirus disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected cases following vaccination in the general population.
M. Patone, X. Mei, L. Handunnetthi, S. Dixon, F. Zaccardi, M. Shankar-Hari, P. Watkinson, K. Khunti, A. Harnden, C. Coupland, K. Channon, N. Mills, Aziz Sheikh, J. Hippisley-Cox   +13 more
semanticscholar   +1 more source

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

New England Journal of Medicine, 2021
Background Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) by May 31, 2021.
D. Mevorach, E. Anis, N. Cedar, M. Bromberg, Eric J Haas, Eyal Nadir, Sharon Olsha-Castell, D. Arad, T. Hasin, N. Levi, R. Asleh, O. Amir, K. Meir, Dotan Cohen, R. Dichtiar, Deborah Novick, Yael Hershkovitz, R. Dagan, I. Leitersdorf, R. Ben-Ami, I. Miskin, Walid Saliba, K. Muhsen, Y. Levi, Manfred S. Green, L. Keinan-Boker, S. alroy-Preis   +26 more
semanticscholar   +1 more source

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation

Frontiers in Cardiovascular Medicine, 2021
Recently, myocarditis following messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination has become an important social issue worldwide. According to the reports so far, myocarditis related to mRNA COVID-19 vaccination is rare and usually ...
Yongwhan Lim, Min Chul Kim, Kye Hun Kim, In-Seok Jeong, Yong Soo Cho, Yoo Duk Choi, Jong Eun Lee   +6 more
doaj   +1 more source

Myocarditis [PDF]

Circulation Research, 2016
Viral myocarditis remains a prominent infectious-inflammatory disease for patients throughout the lifespan. The condition presents several challenges including varied modes of clinical presentation, a range of timepoints when patients come to attention, a diversity of approaches to diagnosis, a spectrum of clinical courses, and unsettled perspectives ...
Gabriel, Fung, Honglin, Luo, Ye, Qiu, Decheng, Yang, Bruce, McManus   +4 more
openaire   +2 more sources

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.

JAMA cardiology, 2021
Importance Myocarditis has been reported with COVID-19 but is not clearly recognized as a possible adverse event following COVID-19 vaccination. Objective To describe myocarditis presenting after COVID-19 vaccination within the Military Health System.
Jay R. Montgomery, M. Ryan, R. Engler, D. Hoffman, B. McClenathan, L. Collins, D. Loran, D. Hrncir, Kelsie Herring, M. Platzer, N. Adams, A. Sanou, L. Cooper   +12 more
semanticscholar   +1 more source

A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis

Diagnostics, 2022
Viral myocarditis is inflammation of the myocardium secondary to viral infection. The clinical presentation of viral myocarditis is very heterogeneous and can range from nonspecific symptoms of malaise and fatigue in subclinical disease to a more florid ...
Adedayo Adeboye, Deya Alkhatib, Asra Butt, Neeraja Yedlapati, Nadish Garg   +4 more
doaj   +1 more source

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

MMWR. Morbidity and mortality weekly report, 2021
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID-19 (mRNA-1273) vaccine,† and the Advisory Committee on Immunization Practices ...
PhD Julia W. Gargano, DrPH Megan Wallace, MD Stephen C. Hadler, MD Gayle Langley, M. P. John R. Su, MD Matthew E. Oster, MD Karen R. Broder, Mph Julianne Gee, Mph Eric Weintraub, MD Tom Shimabukuro, PhD Heather M. Scobie, Mph Danielle Moulia, MD Lauri E. Markowitz, MD Melinda Wharton, JD Veronica V. McNally, MD José R. Romero, MD H. Keipp Talbot, MD Grace M. Lee, MD Matthew F. Daley, MD Sara E. Oliver   +19 more
semanticscholar   +1 more source

Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Prognoses and long‐term cardiac function of patients with fulminant myocarditis have not been fully elucidated. Therefore, we clarified the prognoses and long‐term cardiac function according to required percutaneous mechanical circulatory ...
Toru Kondo, Takahiro Okumura, Naoki Shibata, Takahiro Imaizumi, Kaoru Dohi, Hideo Izawa, Nobuyuki Ohte, Tetsuya Amano, Toyoaki Murohara   +8 more
doaj   +1 more source

Myocarditis [PDF]

Circulation, 1954
A review of selected papers on myocarditis published during the past decade and an analysis of some original data together with personal experiences have been presented. All of these indicate that the clinical diagnosis of myocarditis is made far too infrequently as contrasted with the high incidence of this disease as recognized by ...
C E, DE LA CHAPELLE, C E, KOSSMANN
openaire   +2 more sources